1 report

  • Jun 17, 2016: Zosano Pharma Enrolls First Subject in Pivotal Clinical Trial for ZP-Triptan Patch Program for Treatment of Migraine
  • Jan 05, 2017: Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial

Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings, Inc, is a emerging CNS company that provides pharmaceutical products.The company offers development of transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications. Its lead product...

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation